This inventor holds 35 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Nucleic Acid Sequencing. Top assignees: Illumina Corporation, Arizona State University, Illumina Cambridge Limited. Active years: 2003-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (2003 - 2022)
- Vista, CA (US) (2021 - 2023)
Company Filing History:
34 out of 1,216 
2 out of 2,159 
2 out of 323 
Years Active: 2003-2025
Areas of Expertise:
Title: The Innovative Contributions of David Louis Heiner
Introduction
David Louis Heiner is a prominent inventor based in San Diego, California, with an impressive portfolio that includes 30 patents. His innovations are primarily focused on the field of nucleic acid sequencing and flow cell technology, showcasing his commitment to advancing science and technology.
Latest Patents
One of Heiner's latest patents is the development of a flow cell package and method for making the same. This innovative flow cell package consists of first and second surface-modified patterned wafers separated by interstitial regions, which define fluidic chambers. This design enables high efficiency in fluid handling and is integral to many modern analytical processes.
Another significant patent is the independently removable nucleic acid sequencing system and method. This technique allows for the automated or semi-automated sequencing of nucleic acids by processing sample arrays over multiple cycles. It includes the ability to monitor system parameters for quality control and problem diagnosis during the sequencing process, enhancing the reliability and efficiency of data collection.
Career Highlights
Heiner has contributed to the advancement of biotechnology through his roles at distinguished organizations. He has worked with Illumina Corporation, a leader in genetic sequencing technology, and served on the faculty at Arizona State University, where he has been pivotal in research and innovation within the field of genomics.
Collaborations
Throughout his career, Heiner has collaborated with notable professionals such as Michal Lebl and Robert C. Kain. These collaborations have been crucial in driving forward various innovative projects and achieving groundbreaking results in his research.
Conclusion
David Louis Heiner's contributions to the fields of biotechnology and genetic sequencing continue to influence both academia and industry. With a robust patent portfolio and strong collaborative efforts, Heiner stands as a testament to the impact of innovation in scientific research and technological advancement. His work not only pushes the boundaries of our understanding but also lays the groundwork for future discoveries in nucleic acid technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile